Abstract
This report presents a prospective randomized study of 0.3 percent ofloxacin eardrops for the treatment of active chronic suppurative otitis media. Twenty-nine patients were treated with ofloxacin eardrops for 1 week, and another 27 patients were treated with Augmentin for 1 week. One week after completion of treatment, 22 (76%) patients of the group treated with ofloxacin had dry ears, and only seven (26%) patients treated with Augmentin had dry ears. Ofloxacin eardrops were effective in the initial treatment of active chronic suppurative otitis media.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Adolescent
-
Adult
-
Aged
-
Amoxicillin / therapeutic use
-
Amoxicillin-Potassium Clavulanate Combination
-
Anti-Infective Agents / therapeutic use*
-
Chronic Disease
-
Clavulanic Acids / therapeutic use
-
Drug Therapy, Combination / therapeutic use*
-
Female
-
Humans
-
Instillation, Drug
-
Male
-
Middle Aged
-
Ofloxacin / therapeutic use*
-
Otitis Media, Suppurative / drug therapy*
-
Otitis Media, Suppurative / microbiology
-
Prospective Studies
-
Severity of Illness Index
Substances
-
Anti-Infective Agents
-
Clavulanic Acids
-
Amoxicillin-Potassium Clavulanate Combination
-
Amoxicillin
-
Ofloxacin